| INNOVENT BIOLOGICS INC. |
| China |
| Gesundheit |
| KYG4818G1010 / A2N7N8 |
| 6IB (Frankfurt) |
| FRA:6IB, ETR:6IB, 6IB:GR |
| - |
| http://cn.innoventbio.com.. |
|
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac..
>Volltext.. |
| 15877.85 Mio. EUR |
| 13996.03 Mio. EUR |
| 1360.98 Mio. EUR |
| 267.66 Mio. EUR |
| 134.62 Mio. EUR |
| 0.08 EUR |
| 411.68 Mio. EUR |
| 1153.82 Mio. EUR |
| 258.95 Mio. EUR |
| 1.9 |
| 38.19% |
| - |
| - |
| - |
| - |
| - |
| INNOVENT BIOLOGICS, INNOVENT BIO |
| 27.03.26 |
|